Activation of the renin-angiotensin system within podocytes in diabetes

T-H Yoo1, J-J Li, J-J Kim

  • 1Department of Internal Medicine, College of Medicine, Brain Korea 21, Yonsei University, Seoul, Korea.

Kidney International
|March 16, 2007
PubMed

Insights

High glucose conditions increase key renin-angiotensin system (RAS) components, angiotensinogen (AGT) and angiotensin II (AII) type 1 receptor, in kidney podocytes. This suggests a role for RAS activation in diabetic kidney disease pathogenesis.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • The renin-angiotensin system (RAS) is implicated in diabetic kidney disease.
  • Podocytes are crucial in glomerulosclerosis and proteinuria development.

Purpose of the Study:

  • To investigate the role of RAS components within podocytes in diabetic nephropathy.
  • To examine the effects of high glucose on RAS activation in podocytes.

Main Methods:

  • In vitro studies used immortalized mouse podocytes exposed to normal or high glucose.
  • In vivo studies utilized kidney tissue from streptozotocin-induced diabetic rats.
  • Immunohistochemistry and Western blotting were used to assess RAS components.

Main Results:

  • High glucose significantly increased angiotensinogen (AGT) and angiotensin II (AII) type 1 receptor mRNA and protein in podocytes.
  • Both AII and Angiotensin I levels were elevated in high glucose conditions.
  • Diabetic rats showed increased glomerular AGT and AII type 1 receptor compared to controls.

Conclusions:

  • Increased AGT and AII, along with elevated AII type 1 receptor in podocytes under diabetic conditions, contribute to diabetic nephropathy pathogenesis.
  • Targeting podocyte RAS may offer therapeutic strategies for diabetic kidney disease.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Introduction to Urinary System01:13

Introduction to Urinary System

The urinary system consists of two kidneys, two ureters, the urinary bladder, and the urethra.
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...